TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30461521

Group type: EXPERIMENTAL
Intervention: Nepean Dyspepsia Index (NDI) 25-item form
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Nepean Dyspepsia Index (NDI) 10-item short form
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Nepean Dyspepsia Index (NDI)
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: External instruments for convergent validity
Number of subjects: 289
Study: 29527759

Group type: EXPERIMENTAL
Intervention: Test meal (protein and fat consumed 15 minutes prior to carbohydrates)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard meal (all macronutrients consumed together)
Number of subjects: 20
Study: 26517949

Group type: EXPERIMENTAL
Intervention: Right Ventricular Pacing
Number of subjects: 145
Study: 23225026

Group type: EXPERIMENTAL
Intervention: Recombinant human epidermal growth factor (rhEGF) oral spray
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 23028263

Group type: EXPERIMENTAL
Intervention: Ready-to-use supplementary food (RUSF) 46 g daily for 4 months
Number of subjects: 1038
Study: 19210513

Group type: EXPERIMENTAL
Intervention: rizatriptan 5 mg
Number of subjects: 1819

Group type: EXPERIMENTAL
Intervention: rizatriptan 10 mg
Number of subjects: 1819

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1819
Study: 17761356

Group type: EXPERIMENTAL
Intervention: 5% minoxidil topical foam (MTF)
Number of subjects: 352

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 352
Study: 15090413

Group type: EXPERIMENTAL
Intervention: Topical latanoprost 0.005% once daily for an average duration of 11 months
Number of subjects: 76

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 76
Study: 11795452

Group type: EXPERIMENTAL
Intervention: Microwave treatment (maxillary denture microwaved for one minute at 850 Watts, repeated three times)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control (denture soak treatment in 0.2% chlorhexidine digluconate solution overnight for 14 days)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Microwave treatment
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control (denture soak treatment)
Number of subjects: 34
Study: 9513865

Group type: EXPERIMENTAL
Intervention: Five isometric exercises (medial tibial rotation, knee extension combined, knee extension alone, hip adduction, hip adduction with knee extension)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no PFPS)
Number of subjects: 27
Study: 8743519

Group type: EXPERIMENTAL
Intervention: Nitrendipine (N)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Enalapril (E)
Number of subjects: 28
Study: 2316885

Group type: EXPERIMENTAL
Intervention: Forced-air warming system
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cotton blankets warmed to 37.0 degrees C
Number of subjects: 30
Study: 488520

Group type: EXPERIMENTAL
Intervention: Piracetam 2400 mg daily
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (identical capsules)
Number of subjects: 26
Study: 30551813

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided L5-S1 epidural catheter placement
Number of subjects: 100

Group type: COMPARATOR
Intervention: Non-ultrasound-guided higher lumbar interspace placement
Number of subjects: 100
Study: 25004240

Group type: EXPERIMENTAL
Intervention: Removable appliance with protruding springs
Number of subjects: 64

Group type: COMPARATOR
Intervention: Fixed appliance with multibrackets
Number of subjects: 64
Study: 23220118

Group type: EXPERIMENTAL
Intervention: 4 days of disuse (knee brace)
Number of subjects: 22
Study: 21806694

Group type: EXPERIMENTAL
Intervention: Dietary supplement (placebo pill)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control (placebo pill)
Number of subjects: 154
Study: 19338543

Group type: EXPERIMENTAL
Intervention: BoNT‐A injections (200 U or 100 U) followed by hydrodistention (HD)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Hydrodistention (HD) alone
Number of subjects: 67
Study: 16688845

Group type: EXPERIMENTAL
Intervention: Early removal of nasogastric tube and early oral feeding (experimental group, n=161)
Number of subjects: 316

Group type: COMPARATOR
Intervention: Control group (n=155)
Number of subjects: 316
Study: 15483215

Group type: EXPERIMENTAL
Intervention: Obesity management intervention based on the Transtheoretical Model
Number of subjects: 329

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 329
Study: 11775047

Group type: EXPERIMENTAL
Intervention: Extract of Ginkgo biloba (EGb) plus haloperidol (0.25 mg/kg/day)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo plus haloperidol (0.25 mg/kg/day)
Number of subjects: 109
Study: 9375319

Group type: EXPERIMENTAL
Intervention: Training program on a cycle ergometer
Number of subjects: 9
Study: 1554114

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ketamine
Number of subjects: 20
Study: 3878103

Group type: EXPERIMENTAL
Intervention: Propofol (Diprivan)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Intravenous lignocaine before propofol injection
Number of subjects: 120

Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 120
Study: 31144488

Group type: EXPERIMENTAL
Intervention: Flexible ureteroscopy with ureteral access sheath (UAS)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Flexible ureteroscopy without ureteral access sheath (UAS)
Number of subjects: 131
Study: 29496509

Group type: EXPERIMENTAL
Intervention: FT + NMES
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: FT
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: TRAINING
Number of subjects: 16

Group type: COMPARATOR
Intervention: CON
Number of subjects: 16
Study: 26670679

Group type: EXPERIMENTAL
Intervention: Prodimed (protein shakes)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Standard diet using ordinary products
Number of subjects: 212
Study: 25140908

Group type: EXPERIMENTAL
Intervention: Education and home-based pedometer walking program
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 84
Study: 22241354

Group type: EXPERIMENTAL
Intervention: Aprepitant (APR) administered with conventional antiemetic therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional antiemetic therapy (serotonin receptor antagonist and dexamethasone)
Number of subjects: 20
Study: 20424852

Group type: EXPERIMENTAL
Intervention: Silicone oil suspended with 0.2 mg/ml aspirin (AS SiO)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Silicone oil (control group)
Number of subjects: 29
Study: 18065575

Group type: EXPERIMENTAL
Intervention: 2.8 g alginate-pectin beverage
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 1.0 g alginate-pectin beverage
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (no fiber)
Number of subjects: 29
Study: 16097638

Group type: EXPERIMENTAL
Intervention: Gastroesophageal reflux scintigraphy using the knee-chest position
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Gastroesophageal reflux scintigraphy in the supine position
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Gastroesophageal reflux scintigraphy
Number of subjects: 37
Study: 12399698

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX) varnish treatment after professional tooth cleaning in mothers with high salivary MS counts
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group of untreated mother-child pairs with high maternal salivary MS levels
Number of subjects: 44

Group type: COMPARATOR
Intervention: Negative control group of mother-child pairs with low maternal salivary MS levels
Number of subjects: 44
Study: 10451517

Group type: EXPERIMENTAL
Intervention: Early amniocentesis (EA)
Number of subjects: 3691

Group type: COMPARATOR
Intervention: Mid-trimester amniocentesis (MA)
Number of subjects: 3691

Group type: EXPERIMENTAL
Intervention: Maternal hypertension
Number of subjects: 3691
Study: 7594663

Group type: EXPERIMENTAL
Intervention: PRP‐OMP (Hib polysaccharide conjugated with Neisseria meningitidis group B outer membrane protein complex)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PRP‐T (Hib polysaccharide‐tetanus toxoid conjugate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Three doses of PRP‐OMP or PRP‐T at 4, 6, and 14 months
Number of subjects: 0
Study: 2124027

Group type: EXPERIMENTAL
Intervention: Metoclopramide (10 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: T4 (0.5 mg daily for 6‐14 days)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: T3 (60‐120 micrograms for 6‐8 days)
Number of subjects: 15
Study: 7004624

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (CMFT)
Number of subjects: 318

Group type: COMPARATOR
Intervention: Adjuvant chemotherapy (CMF)
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Estrogen receptor-positive tumors (ER+)
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Estrogen receptor-negative tumors (ER-)
Number of subjects: 318
Study: 31778314

Group type: EXPERIMENTAL
Intervention: CT perfusion imaging (CTPI)
Number of subjects: 33
Study: 31159856

Group type: EXPERIMENTAL
Intervention: Long-term maintenance antidepressants (citalopram, sertraline, fluoxetine, mirtazapine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27686717

Group type: EXPERIMENTAL
Intervention: 16-week home-based rehabilitation (HBR) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care plus written health advice (Control)
Number of subjects: 0
Study: 25885697

Group type: EXPERIMENTAL
Intervention: Recovery MANTRA (6-week self-care intervention supplemented by peer mentorship)
Number of subjects: 0
Study: 24018733

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (1.5 mA, 10 min)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (1.5 mA, 10 min)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham tDCS (10 min)
Number of subjects: 12
Study: 21900088

Group type: EXPERIMENTAL
Intervention: Prothrombin complex concentrate (PCC) 50 IU/kg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 12
Study: 19106242

Group type: EXPERIMENTAL
Intervention: Phytase + NaFeEDTA + ascorbic acid
Number of subjects: 101

Group type: COMPARATOR
Intervention: FeSO4 without enhancers
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Phytase + NaFeEDTA
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Phytase + ascorbic acid + NaFeEDTA
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: L-alpha-glycerophosphocholine
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Calcium with ascorbic acid + NaFeEDTA
Number of subjects: 101
Study: 17302055

Group type: EXPERIMENTAL
Intervention: Xiongshao Capsule (XC)
Number of subjects: 335

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 335
Study: 15118486

Group type: EXPERIMENTAL
Intervention: Donepezil (acetylcholinesterase inhibitor)
Number of subjects: 0
Study: 11561117

Group type: EXPERIMENTAL
Intervention: Joint protection arthritis education programme
Number of subjects: 127

Group type: COMPARATOR
Intervention: Standard arthritis education programme
Number of subjects: 127
Study: 9756169

Group type: EXPERIMENTAL
Intervention: Oral dexamethasone 2 mg/m2 during radiotherapy
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Oral dexamethasone 4 mg/m2 during radiotherapy
Number of subjects: 32
Study: 8161291

Group type: EXPERIMENTAL
Intervention: Low-tryptophan diet (160 mg/d) followed by a drink of 15 amino acids
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (tryptophan-supplemented testing)
Number of subjects: 15
Study: 3825986

Group type: EXPERIMENTAL
Intervention: Nutrient-based method (Diet Guide)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Food-group method (Exchange Lists)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 83
Study: 31843639

Group type: EXPERIMENTAL
Intervention: SleepWell24 smartphone application
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care control condition
Number of subjects: 0
Study: 31692870

Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg/d)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 27995073

Group type: EXPERIMENTAL
Intervention: ADHD childhood diagnosis with cannabis use (n=23)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: ADHD childhood diagnosis without cannabis use (n=22)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Cannabis use without ADHD (n=15)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Non-users without ADHD (n=15)
Number of subjects: 75
Study: 26423732

Group type: EXPERIMENTAL
Intervention: Garlic-containing meal (100 g white bread, 15 g butter, and 5 g raw, crushed garlic)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Garlic-free control meal (100 g white bread and 15 g butter)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Purified garlic extract (0.5 μL/mL) in Mono Mac 6 cells
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Garlic treatment
Number of subjects: 17
Study: 21940462

Group type: EXPERIMENTAL
Intervention: experimental explicit, systematic, code‐based program
Number of subjects: 206

Group type: COMPARATOR
Intervention: typical kindergarten reading intervention
Number of subjects: 206
Study: 21930410

Group type: EXPERIMENTAL
Intervention: Skin traction
Number of subjects: 40

Group type: COMPARATOR
Intervention: No skin traction (Control)
Number of subjects: 40
Study: 18757089

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg daily
Number of subjects: 4574

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4574
Study: 16023823

Group type: EXPERIMENTAL
Intervention: Group support program
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Home visiting program
Number of subjects: 257
Study: 12952518

Group type: EXPERIMENTAL
Intervention: Soft tissue massage (6 treatments)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no treatment, waiting list)
Number of subjects: 29
Study: 10663354

Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Purposeful load‐bearing exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral contraceptives
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Moderate intakes of alcohol and caffeine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Appropriate treatment of endometriosis
Number of subjects: 0
Study: 9063757

Group type: EXPERIMENTAL
Intervention: Diflunisal (500 mg)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Paracetamol (500 mg)
Number of subjects: 104
Study: 1648849

Group type: EXPERIMENTAL
Intervention: Sodium selenite therapy (500 micrograms daily)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (not specified treatment)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sodium selenite therapy
Number of subjects: 8
Study: 6356320

Group type: EXPERIMENTAL
Intervention: sucralfate, 4 g daily
Number of subjects: 121

Group type: COMPARATOR
Intervention: cimetidine, 1 g daily
Number of subjects: 121
Study: 30921489

Group type: EXPERIMENTAL
Intervention: Dried urine spots (DUS) screening method
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Dried urine spots (DUS)
Number of subjects: 49
Study: 29018989

Group type: EXPERIMENTAL
Intervention: Continuous treadmill exercise (65% maximal oxygen consumption)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Quiet rest (REST)
Number of subjects: 11
Study: 26135813

Group type: EXPERIMENTAL
Intervention: Combined PFS and local vaginal estrogen (Group C)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Pelvic floor electrical stimulation (PFS) (Group A)
Number of subjects: 315

Group type: COMPARATOR
Intervention: Local vaginal estrogen (Group B)
Number of subjects: 315
Study: 25567460

Group type: EXPERIMENTAL
Intervention: FSP regimen plus a supplement of 'Parma pap' (Group 2)
Number of subjects: 332

Group type: COMPARATOR
Intervention: FSP portions only (Group 1)
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: 'Parma pap' given to twenty-one malnourished children at Xaverian Mission
Number of subjects: 332
Study: 21873922

Group type: EXPERIMENTAL
Intervention: Office-based vergence/accommodative therapy with home reinforcement (OBVAT)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Home-based computer vergence/accommodative therapy (HBCVAT+)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Home-based pencil push-up therapy (HBPP)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Office-based placebo therapy (OBPT)
Number of subjects: 221
Study: 20396714

Group type: EXPERIMENTAL
Intervention: artrofoon for 12 months in addition to basis therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: basis therapy
Number of subjects: 50
Study: 17581200

Group type: EXPERIMENTAL
Intervention: High-sulphite wine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Low-sulphite wine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo challenge
Number of subjects: 8
Study: 15319721

Group type: EXPERIMENTAL
Intervention: Prerequisite Curriculum (PRC) e-learning system
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group (traditional texts and journals)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: PRC e-learning system
Number of subjects: 138
Study: 11306238

Group type: EXPERIMENTAL
Intervention: Screening for chlamydial infection in nonpregnant women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Screening for chlamydial infection in pregnant women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DNA amplification tests using endocervical swabs in women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DNA amplification tests using urethral swabs in men
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: First-void urine specimens from men and women
Number of subjects: 0

Group type: COMPARATOR
Intervention: Screening for chlamydial infection in men
Number of subjects: 0
Study: 9566667

Group type: EXPERIMENTAL
Intervention: Uncooked vegan diet rich in lactobacilli
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (omnivorous diet)
Number of subjects: 0
Study: 8063620

Group type: EXPERIMENTAL
Intervention: Liposomal adriamycin (Lipo‐ADR)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Free adriamycin (F‐ADR)
Number of subjects: 52
Study: 2927860

Group type: EXPERIMENTAL
Intervention: Amnioinfusion with 1000 mL normal saline initially and every 6 hours until delivery
Number of subjects: 85

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 85
Study: 5039550

Group type: EXPERIMENTAL
Intervention: Fenfluramine
Number of subjects: 39

Group type: COMPARATOR
Intervention: Phentermine
Number of subjects: 39
Study: 31290278

Group type: EXPERIMENTAL
Intervention: Parenting program
Number of subjects: 77

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 77
Study: 26918815

Group type: EXPERIMENTAL
Intervention: Group-based dance exergaming (36 hours over 3 months)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Self-directed care control condition
Number of subjects: 41
Study: 26364765

Group type: EXPERIMENTAL
Intervention: Bepotastine besilate (10 mg orally twice daily for 2 weeks)
Number of subjects: 473

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 473
Study: 22789310

Group type: EXPERIMENTAL
Intervention: 20min post-warm-up recovery
Number of subjects: 8

Group type: COMPARATOR
Intervention: 45min post-warm-up recovery
Number of subjects: 8
Study: 20697755

Group type: EXPERIMENTAL
Intervention: Sealed with polyurethane-dimethacrylate foil using bonding
Number of subjects: 50

Group type: COMPARATOR
Intervention: Oral home care (Control)
Number of subjects: 50
Study: 18425006

Group type: EXPERIMENTAL
Intervention: Complete resection (n = 122)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Incomplete resection (n = 121)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Patients with residual tumor
Number of subjects: 243

Group type: COMPARATOR
Intervention: Patients without residual tumor
Number of subjects: 243
Study: 16494704

Group type: EXPERIMENTAL
Intervention: Early discharge at > or = 1650 g
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine discharge at > or = 1800 g
Number of subjects: 120
Study: 12970329

Group type: EXPERIMENTAL
Intervention: Valsartan 160 mg daily
Number of subjects: 32

Group type: COMPARATOR
Intervention: Simvastatin 80 mg daily
Number of subjects: 32

Group type: COMPARATOR
Intervention: Quinapril 40 mg daily
Number of subjects: 32

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 32
Study: 10723240

Group type: EXPERIMENTAL
Intervention: KW‐2228 (rhG‐CSF)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 98
Study: 9370111

Group type: EXPERIMENTAL
Intervention: Etomoxir (100 mg/day for 3 days)
Number of subjects: 12
Study: 1283591

Group type: EXPERIMENTAL
Intervention: Verapamil 240 mg/day for 14 days
Number of subjects: 14

Group type: COMPARATOR
Intervention: High sodium intake (11 g/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Low sodium intake (4 g/day)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Verapamil treatment
Number of subjects: 14
Study: 4026927

Group type: EXPERIMENTAL
Intervention: Sulfadiazine (4 mg/kg twice daily, initial dose 8 mg/kg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sulfafurazole (50 mg/kg four times a day)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sulfadiazine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sulfafurazole
Number of subjects: 16
Study: 31420812

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injection
Number of subjects: 98

Group type: COMPARATOR
Intervention: Corticosteroid injection
Number of subjects: 98
Study: 29976165

Group type: EXPERIMENTAL
Intervention: Active air purifier (Atmosphere; Amway China)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Inactive air purifier (placebo)
Number of subjects: 60
Study: 27909165

Group type: EXPERIMENTAL
Intervention: High-dose psilocybin (22 or 30 mg/70 kg)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo-like dose (1 or 3 mg/70 kg)
Number of subjects: 51
Study: 25141203

Group type: EXPERIMENTAL
Intervention: Papacarie™ gel for chemo‐mechanical caries removal
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional caries removal with a low‐speed bur
Number of subjects: 20
Study: 22852802

Group type: EXPERIMENTAL
Intervention: Web-based smoking cessation program (Decide2Quit)
Number of subjects: 1488